Layered uncertainties make this case an unusually difficult case in which to predict the outcome
On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, “Under what conditions, if any, are isolated human genes patentable?” Kevin Emerson Collins, JD, patent law expert and professor of law at Washington University in St. Louis, believes that layered uncertainties make this case an unusually difficult case in which to predict the outcome.
During the early 1990s, Myriad Genetics made important scientific discoveries related to mutations in the BRCA 1 and BRCA 2 genes, which are biomarkers for increased risk of breast and ovarian cancer. Based on this work, Myriad sought, and obtained, patent protection for “isolated” DNA molecules that embody these sequences.
The Supreme Court’s opinion in Myriad will determine whether Myriad’s gene patents are valid or, alternatively, whether they were improperly issued from the beginning.
“The legal controversy centers on patent law’s ‘products of nature’ doctrine—a doctrine that prevents the patenting of newly made products that do not display a ‘marked difference’ from naturally occurring products,” Collins says.
“A perfectly circular section cut out of a leaf of a newly discovered plant may be technically new at the time that it is first made – and it may be socially useful if the leaf contains chemicals that are natural wound healers, but it’s likely an unpatentable product of nature because there is no marked difference between the newly created product and the naturally occurring product.
“Importantly, the Myriad gene patents only encompass DNA molecules in an ‘isolated’ state, separate from the remainder of the chromosome in which they exist in a human body, and they thus describe molecules that were technically new when Myriad first made them.”
The question before the Court is whether the structural and functional differences between naturally occurring DNA molecules and DNA molecules in an isolated state is sufficiently significant to constitute a “marked difference” and to sanction the patenting of the isolated DNAs.
Behind the legal controversy is an economic controversy that may (or may not) influence the Supreme Court’s pronouncement on the products of nature doctrine. “The social costs of the exclusive rights to inventions granted by patents are normally justified by the incentives that patents provide for self-interested entities to invest in research and development and generate the socially valuable inventions,” Collins says.
However, under some circumstances, there are legitimate concerns that the incentive-based benefits of patents may not outweigh these costs.
“One function of the products of nature doctrine is to ensure that the basic tools of scientific and technological work are not constrained by claims of patent rights and remain free for all to use as inputs into future research,” says Collins.
“To the extent that isolated genes are essential technological and scientific building blocks, the costs of Myriad’s gene patents in the form of slower innovation in the future may be so great that they will outweigh the benefits of the patent-induced incentives that speed up the creation of the isolated genes themselves.”
The verdict
The Latest Bing News on:
Are human genes patentable
- Almost All People With Two Copies of This Genetic Variant Develop Signs of Alzheimer’s Disease, Study Findson May 7, 2024 at 2:13 pm
The research focused on a variant called APOE4 and largely looked at people of European ancestry—risk levels are different for other groups, the authors say ...
- You're Practically Guaranteed to Get Alzheimer's If You Have This Genetic Varianton May 7, 2024 at 1:01 pm
Recent research indicates that people with two copies of the APOE4 gene are almost certain to exhibit signs of the neurological disease by their mid-60s.
- Gene mutation may signal new genetic form of Alzheimer's diseaseon May 7, 2024 at 10:53 am
People who carry two copies of the gene mutation most strongly implicated in Alzheimer's disease are almost certain to develop brain changes related to the degenerative disorder, a new study says.
- Genes affecting worm behavior found to be relevant to neurological disease in humanson April 30, 2024 at 10:46 pm
As an undergraduate student in The University of Texas at Arlington's Honors College, Hannah Selvarathinam knew she wanted to conduct research. Near the end of her first year at UTA, the Keller native ...
- Study finds some people have a uniquely human gene that enhances immune functionon April 30, 2024 at 7:50 am
University at Buffalo researchers have found that the active form of a gene promotes a broad range of protective traits. The gene is found in 75% of the population and is known to protect against ...
- How Quantum Computers Could Illuminate the Full Range of Human Genetic Diversityon April 26, 2024 at 10:26 am
Pangenomes that incorporate many people’s DNA could capture the breadth of human genetic diversity, and quantum computers may be a key enabler.
- The scramble to patent human geneson April 14, 2024 at 6:35 pm
Most biologists know that the human genome, with its 100,000 or so genes, is expected to be fully ... appear to be patentable, at least in the United States, where the US Patent and Trademark ...
- Second International Summit on Human Gene Editingon March 9, 2024 at 1:49 pm
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
- Study reveals genes that set humans apart from other primates in cognitive abilityon December 4, 2023 at 4:00 pm
An international team led by researchers at the University of Toronto has uncovered over 100 genes that are common to primate brains but have undergone evolutionary divergence only in humans – and ...
- Revealing the Genes that Shape the Human Brainon August 1, 2022 at 9:50 am
Neurologist Christopher Walsh discovered genes that direct cerebral cortex development. We asked him what they reveal about intelligence, psychiatric disorders, and the nature of being human This ...
The Latest Google Headlines on:
Are human genes patentable
[google_news title=”” keyword=”Are human genes patentable” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Gene patents
- Patient dies in Pfizer study of Duchenne gene therapyon May 7, 2024 at 2:39 pm
Pfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The company is working with trial researchers to investigate further.
- German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Brukeron May 7, 2024 at 11:05 am
Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the ...
- Exclusive: Feng Zhang CRISPR startup gathers patents, locking up rights to family of editing techon May 7, 2024 at 4:00 am
In the bid to lock up patent rights to a growing suite of gene-editing technologies, Arbor Biotechnologies has acquired a small startup founded by MIT scientist and CRISPR pioneer Feng Zhang, the ...
- Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvardon May 6, 2024 at 4:59 pm
Vizgen cited as examples of anticompetitive activities what it called the unlawful bundling of 10x Genomics’ existing Chromium Single Cell Immune Profiling platform, and its Visium Spatial Gene ...
- Research team develops fast-track process for genetic improvement of plant traitson May 6, 2024 at 12:10 pm
Researchers interested in improving a given trait in plants can now identify the genes that regulate the trait's expression without doing any experiments.
- Livestock genome patent case rears head again with fresh court actionon April 30, 2024 at 11:05 pm
A long-running and controversial livestock genetics patent case has returned with five Australian industry groups including Meat & Livestock Australia now defending a new legal challenge in the ...
- Alnylam Pharmaceuticals gets grant for inhibiting expression of serum amyloid a geneon April 30, 2024 at 5:45 am
Discover the groundbreaking patent by Alnylam Pharmaceuticals Inc for a dsRNA molecule targeting Serum Amyloid A gene expression. Learn about the innovative design and potential applications in ...
- Cell and gene therapy companies trip at scalability hurdleon April 29, 2024 at 3:09 am
Experts hold scalability challenges and high costs accountable for market failures within the cell and gene therapy landscape.
- NxGen founder fires back at Penn and Dr. James Wilson in lawsuit over 'decade-long nightmare'on April 25, 2024 at 11:42 am
The one-time postdoctoral researcher alleges her "life’s work is being held hostage" by Penn and Dr. James Wilson, director of the university's gene therapy program.
- Meeting the cell and gene therapy scale-up challengeon April 25, 2024 at 9:00 am
One of the pivotal challenges in the development and commercialisation of cell and gene therapies (CGT) lies in scaling up production. This challenge is particularly pronounced as companies transition ...
The Latest Google Headlines on:
Gene patents
[google_news title=”” keyword=”gene patents” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]